Showing 1 - 3 results of 3 for search 'Kevin M. Dennehy', query time: 0.02s Refine Results
  1. 1
    Comparison of the Development of SARS-Coronavirus-2-Specific Cellular Immunity, and Central Memory CD4+ T-Cell Responses Following Infection versus Vaccination

    Comparison of the Development of SARS-Coronavirus-2-Specific Cellular Immunity, and Central Memory CD4+ T-Cell Responses Following Infection versus Vaccination by Kevin M. Dennehy, Eva Löll, Christine Dhillon, Johanna-Maria Classen, Tobias D. Warm, Lukas Schuierer, Alexander Hyhlik-Dürr, Christoph Römmele, Yvonne Gosslau, Elisabeth Kling, Reinhard Hoffmann

    Published 2021-12-01
    Get full text
    Article
  2. 2
    One Year after Mild COVID-19: The Majority of Patients Maintain Specific Immunity, But One in Four Still Suffer from Long-Term Symptoms

    One Year after Mild COVID-19: The Majority of Patients Maintain Specific Immunity, But One in Four Still Suffer from Long-Term Symptoms by Andreas Rank, Athanasia Tzortzini, Elisabeth Kling, Christoph Schmid, Rainer Claus, Eva Löll, Roswitha Burger, Christoph Römmele, Christine Dhillon, Katharina Müller, Philipp Girl, Reinhard Hoffmann, Stefanie Grützner, Kevin M. Dennehy

    Published 2021-07-01
    Get full text
    Article
  3. 3
    Targeted in-vitro-stimulation reveals highly proliferative multi-virus-specific human central memory T cells as candidates for prophylactic T cell therapy.

    Targeted in-vitro-stimulation reveals highly proliferative multi-virus-specific human central memory T cells as candidates for prophylactic T cell therapy. by Benjamin Faist, Fabian Schlott, Christian Stemberger, Kevin M Dennehy, Angela Krackhardt, Mareike Verbeek, Götz U Grigoleit, Matthias Schiemann, Dieter Hoffmann, Andrea Dick, Klaus Martin, Martin Hildebrandt, Dirk H Busch, Michael Neuenhahn

    Published 2019-01-01
    Get full text
    Article

Search Tools: